INVITROGEN CORPORATION for INVITROGEN CORPORATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
H.R. 1908, S. 1145 Patent Reform legislation -- against inclusion of a research use exemption provision in patent reform legislation. Concerns regarding post grant opposition and apportionment of damages provisions. HR 977 - re Gene Patents, Against; against inclusion of a research use exemption
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Budget/Appropriations BUD
S 1710 - for increased funding for NIH, in favor of the LHHS conference report; in favor of the veto overrride FY08 DoD Appropriations Bill, HR 3222 - for biodefense funding FY08 LHHS Appropriations Bill, HR 3043 - for increased funding for NIH, in favor of the LHHS conference report; in favor of the veto overrride; FY08 Consolidated Appopriations HR 2764 - for increased biomedical research funding/NIH
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.